Hyaluronan Accelerates Intestinal Mucosal Healing through Interaction with TSG-6

Area of Science:

• Gastroenterology
• Regenerative Medicine
• Immunology

Background:

• Hyaluronan (HA) shows therapeutic potential in various diseases.
• Local HA application improves outcomes in active distal ulcerative colitis (UC).
• Mechanisms underlying HA's benefits in UC are not fully understood.

Purpose of the Study:

• To investigate the mechanisms by which HA promotes mucosal healing in ulcerative colitis.
• To determine the role of TSG-6 in HA-mediated intestinal epithelial regeneration.

Main Methods:

• In vitro and in vivo studies using mouse models of colitis.
• Administration of HA and saline as controls.
• Histological analysis of mucosal healing and epithelial regeneration.
• Measurement of TSG-6 levels in UC patients and mice.
• Assessment of HA's effects in TSG-6 deficient mice.

Main Results:

• HA treatment accelerated intestinal epithelial regeneration and mucosal healing in mice with colitis.
• Mice treated with HA showed reduced endoscopic and histological signs of inflammation and faster recovery.
• Mucosal levels of TSG-6 were elevated in UC patients and after wounding in mice.
• TSG-6 deletion abrogated the beneficial effects of HA on mucosal wound repair.

Conclusions:

• HA promotes mucosal healing in ulcerative colitis by accelerating intestinal epithelial regeneration.
• The interaction between HA and TSG-6 is critical for HA's therapeutic effects in the gut.
• HA represents a promising therapeutic agent for promoting mucosal healing in UC.